Skip to content

Insider trading? Health subcommittee member buys stock before lawsuit settlement

Insider trading? Health subcommittee member buys stock before lawsuit settlement
Elmaz Sabovic

Insider traders often operate on undisclosed information, giving them an unfair edge in forecasting stock market movements. 

In this case, U.S. Representative Earl Blumenauer appeared to know about a favorable judicial decision regarding Koninklijke Philips (NYSE: PHG) and its U.S. respiratory lawsuit. 

The stock has surged by 28.57% following Blumenauer’s purchase, with a 26% gain over the last three trading sessions, conveniently aligning with the verdict’s delivery as Blumenauer purchased the stock on February 12 and disclosed the purchase on March 2.

PHG stock has surged since Blumenauer's purchase. Source: Quiver Quantitative
PHG stock has surged since Blumenauer’s purchase. Source: Quiver Quantitative

Blumenauer’s position on the health subcommittee makes this trade even more suspicious.

Philips US settlement and quarterly results caused the surge

Philips, the medical device manufacturer, reached a nearly $1.1 billion settlement for personal injury claims related to certain CPAP, ventilator, and BiPAP machines following a major recall in 2021

Additionally, a $25 million settlement for medical monitoring was agreed upon. Despite not admitting fault or liability, Philips aimed to compensate individuals in the US who sued, alleging harm from the faulty devices. 

In addition to an unlimited settlement offering over $600 million in economic compensation to affected device owners, the latest agreement has been reached.

The settlement announcement coincided with Philips’ first-quarter financial results, which were mainly positive and aligned with expectations, leading to a significant rise in PHG stock. 

PHG stock price chart

With the positive developments during recent trading sessions, PHG stock is trading at a price of $26.55 after experiencing a slight setback of 0.60% in the last trading session. This is negated by a significant gain of 26.61% in the previous five trading sessions.

On a YTD chart, PHG shares show a healthy progress of 14.34%.

PHG stock YTD price chart. Source: Google Finance
PHG stock YTD price chart. Source: Google Finance

With the legal roadblocks cleared, Philips seems set to reclaim its lost share of the US healthcare industry, potentially yielding Blumenauer even more profits.

Buy stocks now with eToro – trusted and advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.